We are today announcing the appointment of Sally Clark to the Bupa Board as a Non-Executive Director and a member of the Audit, Remuneration and Risk Committees from 1 July 2022.
Sally brings over 30 years’ experience in internal audit and risk management in financial services, including having been Chief Internal Auditor at Barclays where she managed a large, global team and drove award-winning learning and development activities, as well as sponsoring Barclays’ wellbeing agenda. She has non-executive experience through her current roles at Citigroup Global Markets Limited, Acin Limited and KORE Limited, and also her role on the board of Metro Bank plc, from which she will step down on 30 June 2022.
Roger Davis, Chairman said: “I am delighted to welcome Sally to the Board. Her appointment brings additional financial services expertise to the Board, as well as a strong track record in people development and employee wellbeing, which will further strengthen the audit, risk and remuneration committees, and I look forward to working with her.”
Notes to editors
Enquiries
Investors: Gareth Evans (Treasury): [email protected]
BUPA 1025Z LN
About Bupa
Bupa's purpose is helping people live longer, healthier, happier lives and making a better world.
We are an international healthcare company serving over 38 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers.
We directly employ around 84,000 people, principally in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong SAR, Türkiye, Brazil, Mexico, the US, Middle East and Ireland. We also have associate businesses in Saudi Arabia and India.
